Gastroparesis Flashcards
(19 cards)
Scintigraphic gastric emptying assessment is the standard test for the evaluation of GP in patients w/ upper GI symptoms. The suggested method of testing includes appraising the emptying of a solid meal over a duration of 3h or greater.
strong, moderate evidence
ROM testing is not suggested for diagnostic evaluation of GP w/ upper GI symptoms
conditional, very low evidence
WMC testing may be an alternative to the SGE assessment for evaluation of GP w/ upper GI symptoms
conditional, low evidence
Stable isotope breath test is a reliable test for evaluation of GP w/ upper GI symptoms
conditional, low evidence
Dietary management of GP should include a small particle diet to increase likelihood of symptom relief
conditional, low evidence
In patients w/ idiopathic and diabetic gastroparesis, pharmacologic treatment should be considered
conditional, low evidence
Suggest treatment w/ metoclopramide over no treatment for management of refractory symptoms
conditional, low evidence
Where domperidone is approved, suggest the use of domperidone
conditional, low evidence
Suggest use of 5-HT4 agonists over no treatment to improve GE
conditional, low evidence
Use of antiemetic agents is suggested for improved symptom control; however, these medications do not improve GE
conditional, low evidence
Central neuromodulators are not recommended for management of GP
strong, moderate evidence
Current data do NOT support the use of ghrelin agonists for management of GP
strong, moderate evidence
Current data do NOT support the use of haloperidol for treatment of GP
conditional, low evidence
Gastric electric stimulation may be considered for control of GP symptoms as a humanitarian use device
conditional, low evidence
Acupuncture alone or acupuncture combined w/ pro kinetic drugs may be beneficial for symptom control in patients with diabetic gastroparesis. Acupuncture cannot be recommended as beneficial for other etiologies of gastroparesis.
conditional, very low evidence
Herbal therapies such as Rikkunshito or STW5 (Iberogast) should NOT be recommended for treatment of GP
conditional, low evidence
In patients w/ GP, EndoFLIP evaluation may have a role in characterizing pyloric function and predicting treatment outcomes after peroral pyloromyotomy
conditional, very low evidence
Intrapyloric injection of botulinum toxin is not recommended for patients w/ GP based on RCTs
strong, moderate evidence
In patients w/ GP w/ symptoms refractory to medical therapy, suggest pyloromyotomy over no treatment for symptom control
conditional, low evidence
